HZNP Share Price

Open 12.11 Change Price %
High 12.37 1 Day 0.16 1.32
Low 11.95 1 Week 0.16 1.32
Close 12.27 1 Month -0.85 -6.48
Volume 2021226 1 Year -7.14 -36.79
52 Week High 21.98
52 Week Low 9.45
HZNP Important Levels
Resistance 2 12.66
Resistance 1 12.50
Pivot 12.20
Support 1 12.04
Support 2 11.88
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.02 100.00%
RITT 0.02 100.00%
LOCM 0.09 50.00%
SCHS 0.04 33.33%
GEVO 0.81 32.79%
MRGE 0.55 30.95%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CYCC 2.24 21.74%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Horizon Pharma, Inc. (NASDAQ: HZNP)

HZNP Technical Analysis 3
As on 21st Sep 2017 HZNP Share Price closed @ 12.27 and we RECOMMEND Sell for LONG-TERM with Stoploss of 14.75 & Sell for SHORT-TERM with Stoploss of 12.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
HZNP Target for September
1st Target up-side 15.16
2nd Target up-side 16.2
3rd Target up-side 17.24
1st Target down-side 12.2
2nd Target down-side 11.16
3rd Target down-side 10.12
HZNP Other Details
Segment EQ
Market Capital 138607328.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.horizonpharma.com
HZNP Address
HZNP
520 Lake Cook Road
Suite 520
Deerfield, IL 60015
United States
Phone: 224-383-3000
Fax: 224-383-3001
HZNP Latest News
Interactive Technical Analysis Chart Horizon Pharma, Inc. ( HZNP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Horizon Pharma, Inc.
HZNP Business Profile
Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.